70
Views
1
CrossRef citations to date
0
Altmetric
Articles

Use and knowledge of novel synthetic opioids: An Italian survey

ORCID Icon, ORCID Icon, , , , ORCID Icon, , , , & show all

References

  • Acuna, V. S., Abels, E. M., Alhelwani, A., & Alzghari, S. K. (2020, March). Treating non-fentanyl-derived synthetic opioid overdose with a traditional opioid reversal agent. Cureus, 12(3), e7241. https://doi.org/10.7759/cureus.7241
  • Arillotta, D., Schifano, F., Napoletano, F., Zangani, C., Gilgar, L., Guirguis, A., Corkery, J. M., Aguglia, E., & Vento, A. (2020). Novel opioids: Systematic web crawling within the e-psychonauts' scenario. Frontiers in Neuroscience, 14, 149. https://doi.org/10.3389/fnins.2020.00149
  • Bach, H., Jenkins, V., Aledhaim, A., Moayedi, S., Schenkel, S. M., & Kim, H. K. (2020). Prevalence of fentanyl exposure and knowledge regarding the risk of its use among emergency department patients with active opioid use history at an urban medical center in Baltimore, Maryland. Clinical Toxicology, 58(6), 460–465. https://doi.org/10.1080/15563650.2019.1657583
  • Baumann, M. H., Majumdar, S., Le Rouzic, V., Hunkele, A., Uprety, R., Huang, X. P., Xu, J., Roth, B. L., Pan, Y.-X., & Pasternak, G. W. (2018). Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace. Neuropharmacology, 134(Pt A), 101–107. https://doi.org/10.1016/j.neuropharm.2017.08.016
  • Boublik, J. H., Quinn, M. J., Clements, J. A., Herington, A. C., Wynne, K. N., & Funder, J. W. (1983). Coffee contains potent opiate receptor binding activity. Nature, 301(5897), 246–248. https://doi.org/10.1038/301246a0
  • Carelli, R. M. (2002). The nucleus accumbens and reward: Neurophysiological investigations in behaving animals. Behavioral and Cognitive Neuroscience Reviews, 1(4), 281–296. https://doi.org/10.1177/1534582302238338
  • EMCDDA. (2019). European drug report 2019: Trends and developments. Retrieved March 16, 2020 from http://www.emcdda.europa.eu/system/files/publications/11364/20191724_TDAT19001ENN_PDF.pdf
  • Evans-Brown, M., Gallegos, A., Christie, R., Sola, S., Almeida, A., Jorge, R., De Morais, J., & Sedefov, R. (2018). Fentanils and synthetic cannabinoids: Driving greater complexity into the drug situation. https://www.emcdda.europa.eu/system/files/publications/8870/2018-2489-td0118414enn.pdf
  • Fairbairn, N., Coffin, P. O., & Walley, A. Y. (2017). Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic. The International Journal on Drug Policy, 46, 172–179. https://doi.org/10.1016/j.drugpo.2017.06.005
  • Frisoni, P., Bacchio, E., Bilel, S., Talarico, A., Gaudio, R., Barbieri, M., Neri, M., & Marti, M. (2018). Novel synthetic opioids: The pathologist’s point of view. Brain Sciences, 8(9), 170. https://doi.org/10.3390/brainsci8090170
  • Guzzo, L. S., Romero, T. R., Queiroz-Junior, C. M., Caliari, M. V., Azevedo, A. O., Perez, A. C., & Duarte, I. D. (2015). Involvement of endogenous opioid peptides in the peripheral antinociceptive effect induced by the coffee specific diterpene kahweol. Pharmacological Reports: PR, 67(5), 1010–1015. https://doi.org/10.1016/j.pharep.2015.02.009
  • Horsfall, J. T., & Sprague, J. E. (2017). The pharmacology and toxicology of the 'Holy Trinity'. Basic & Clinical Pharmacology & Toxicology, 120(2), 115–119. https://doi.org/10.1111/bcpt.12655
  • Kraus, M., Lintzeris, N., Maier, C., & Savage, S. (2016). Recommendations for the prevention, detection, treatment and management of prescription opioid analgesic dependence: Outcomes from the opioid analgesic dependence education nexus (OPEN) meeting. International Journal of Mental Health and Addiction, 14, 313–321. https://doi.org/10.1007/s11469-015-9590-x
  • Lovrecic, B., Lovrecic, M., Gabrovec, B., Carli, M., Pacini, M., Maremmani, A. G. I., & Maremmani, I. (2019). Non-medical use of novel synthetic opioids: A new challenge to public health. International Journal of Environmental Research and Public Health, 16(2), 177. https://doi.org/10.3390/ijerph16020177
  • Mackey, T. K., & Kalyanam, J. (2017). Detection of illicit online sales of fentanyls via Twitter. F1000Research, 6, 1937. https://doi.org/10.12688/f1000research.12914.1
  • McIntyre, I. M., Trochta, A., Gary, R. D., Wright, J., & Mena, O. (2016). An acute butyr-fentanyl fatality: A case report with postmortem concentrations. Journal of Analytical Toxicology, 40(2), 162–166. https://doi.org/10.1093/jat/bkv138
  • Misailidi, N., Papoutsis, I., Nikolaou, P., Dona, A., Spiliopoulou, C., & Athanaselis, S. (2018). Fentanyls continue to replace heroin in the drug arena: The cases of ocfentanil and carfentanil. Forensic Toxicology, 36(1), 12–32. https://doi.org/10.1007/s11419-017-0379-4
  • Miuli, A., Stigliano, G., & Lalli, A. (2020). “Purple Drank" (codeine and promethazine cough syrup): A systematic review of a social phenomenon with medical implications. Journal of Psychoactive Drugs, 1–10. https://doi.org/10.1080/02791072.2020.1797250
  • Nair, A. S. (2017). Transdermal fentanyl patch in post-operative patients: Is it justified? Indian Journal of Anaesthesia, 61(8), 682–683. https://doi.org/10.4103/ija.IJA_349_17
  • Pichini, S., Solimini, R., Berretta, P., Pacifici, R., & Busardò, F. P. (2018). Acute intoxications and fatalities from illicit fentanyl and analogues: An update. Therapeutic Drug Monitoring, 40(1), 38–51. https://doi.org/10.1097/FTD.0000000000000465
  • Raffa, R. B., Pergolizzi, J. V. J., LeQuang, J. A., Taylor, R. J., Colucci, S., & Annabi, M. H. (2018). The fentanyl family: A distinguished medical history tainted by abuse. Journal of Clinical Pharmacy and Therapeutics, 43(1), 154–158. https://doi.org/10.1111/jcpt.12640
  • Simonato, P., Corazza, O., Santonastaso, P., Corkery, J., Deluca, P., Davey, Z., Blaszko, U., & Schifano, F. (2013). Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey. Human Psychopharmacology, 28(4), 324–331. https://doi.org/10.1002/hup.2300
  • Smith, C. R., Truver, M. T., & Swortwood, M. J. (2019). Quantification of U-47700 and its metabolites in plasma by LC-MS/MS. Journal of Chromatography B, 1112, 41–47. https://doi.org/10.1016/j.jchromb.2019.02.026
  • Solimini, R., Pichini, S., Pacifici, R., Busardò, F. P., & Giorgetti, R. (2018). Pharmacotoxicology of non-fentanyl derived new synthetic opioids. Frontiers in Pharmacology, 9, 654. https://doi.org/10.3389/fphar.2018.00654
  • Stoicea, N., Costa, A., Periel, L., Uribe, A., Weaver, T., & Bergese, S. D. (2019). Current perspectives on the opioid crisis in the US healthcare system: A comprehensive literature review. Medicine, 98(20), e15425. https://doi.org/10.1097/MD.0000000000015425
  • Tabarra, I., Soares, S., Rosado, T., Gonçalves, J., Luís, Â., Malaca, S., Barroso, M., Keller, T., Restolho, J., & Gallardo, E. (2019). Novel synthetic opioids - Toxicological aspects and analysis. Forensic Sciences Research, 4(2), 111–140. https://doi.org/10.1080/20961790.2019.1588933
  • Ujváry, I., Jorge, R., Christie, R., Le Ruez, T., Danielsson, H. V., Kronstrand, R., Elliott, S., Gallegos, A., Sedefov, R., & Evans-Brown, M. (2017). Acryloylfentanyl, a recently emerged new psychoactive substance: A comprehensive review. Forensic Toxicology, 35(2), 232–243. https://doi.org/10.1007/s11419-017-0367-8
  • Van Hout, M. C., Benschop, A., Bujalski, M., Dąbrowska, K., Demetrovics, Z., Felvinczi, K., Hearne, E., Henriques, S., Kaló, Z., Kamphausen, G., Korf, D., Silva, J. P., Wieczorek, Ł., & Werse, B. (2018). Health and social problems associated with recent novel psychoactive substance (NPS) use amongst marginalised, nightlife and online users in six European countries. International Journal of Mental Health and Addiction, 16(2), 480–495. https://doi.org/10.1007/s11469-017-9824-1
  • Wang, S. (2019). Historical review: Opiate addiction and opioid receptors. Cell Transplantation, 28(3), 233–238. https://doi.org/10.1177/0963689718811060
  • Zevin, S., & Benowitz, N. L. (1999). Drug interactions with tobacco smoking. An update. Clinical Pharmacokinetics, 36(6), 425–438. https://doi.org/10.2165/00003088-199936060-00004

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.